Skip to content

Effect of Electromyostimulation on Bone

Effects of Whole-Body Electromyostimulation on Osteoporosis and Sarcopenia in Independently Living, Frail Elderly Females

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01296776
Enrollment
78
Registered
2011-02-15
Start date
2011-01-31
Completion date
2012-12-31
Last updated
2015-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Falls, Osteopenia, Sarcopenia

Keywords

exercise, whole-body electromyostimulation, bone mineral density, falls, physical fitness, pain

Brief summary

Although there is some evidence that whole body electromyostimulation(WB-EMS) affect bone via its acute and longitudinal effects on muscle mass and strength, the corresponding impact on bone density and falls in older adults has not been assessed yet. The investigators hypothesize that WB-EMS significantly affects bone parameters as assessed by DXA, and significantly reduce fall rate and ratio in a cohort of frail elderly women.

Interventions

OTHERwellness control group.

Light physical exercise and relaxation program once a week in blocks of 10 weeks with breaks of 10 weeks between the blocks. The low-intensity, low-volume program was designed to avoid impact on our endpoints.

3 sessions of 18 min/14 (1,5 x week)days over 12 months. 10 low-intensity/low amplitude exercises with electromyostimulation equipment with 85 Hz with periods of 6 sec of current and 4 sec of rest.

Sponsors

City of Erlangen
CollaboratorUNKNOWN
Behinderten- und Versehrten-Sportverband Bayern e.V.
CollaboratorOTHER
Institute of Physical Education and Sports Sciences
CollaboratorOTHER
University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
70 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* female gender * 70 years and older * osteopenia according to WHO * BMI \< 24 kg/m2 * living independently in the area of Erlangen-Nurnberg

Exclusion criteria

* medication or diseases affecting bone metabolism (including HRT) * \> 1 hour/week of exercise * epilepsy, grave neurologic disturbances, * cardiac pacemaker, grave circulatory disorders, * abdomen/groin hernia, * tuberculosis, * cancer, * inflammable diseases, * bleeding tendencies,

Design outcomes

Primary

MeasureTime frameDescription
Bone Mineral Density at the lumbar spine and femoral neck regionbaseline - after 12 monthsBone Mineral Density as assessed by Dual Energy X-ray Absorptiometry
Fallsthroughout the 12 month study periodFall frequency and fall related injuries as assessed by the calendar method

Secondary

MeasureTime frameDescription
maximum strength (trunk and leg extension, grip strength)baseline - after 12 months
Pain frequency and magnitude at various skeletal sites (including low back pain)baseline - after 12 monthsas assessed by questionnaires

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026